Poolbeg Pharma PLC
LSE:POLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Poolbeg Pharma PLC
LSE:POLB
|
UK |
|
IRB Infrastructure Developers Ltd
NSE:IRB
|
IN |
|
Koninklijke BAM Groep NV
AEX:BAMNB
|
NL |
|
N
|
New Gold Inc
XMUN:32N
|
CA |
|
Parkway Life Real Estate Investment Trust
SGX:C2PU
|
SG |
|
Adaro Energy Indonesia TBK PT
IDX:ADRO
|
ID |
|
Asian Television Network International Ltd
XTSX:SAT
|
CA |
|
Dufry AG
SIX:DUFN
|
CH |
|
Cenergy Holdings SA
XBRU:CENER
|
BE |
|
Bucher Industries AG
SIX:BUCN
|
CH |
|
Lion Copper and Gold Corp
OTC:LCGMF
|
CA |
|
A
|
Addiko Bank AG
VSE:ADKO
|
AT |
Wall St Price Targets
POLB Price Targets Summary
Poolbeg Pharma PLC
According to Wall Street analysts, the average 1-year price target for POLB is 19.38 GBX with a low forecast of 19.19 GBX and a high forecast of 19.95 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is POLB's stock price target?
Price Target
19.38
GBX
According to Wall Street analysts, the average 1-year price target for POLB is 19.38 GBX with a low forecast of 19.19 GBX and a high forecast of 19.95 GBX.